InvestorsHub Logo

TOB

Followers 162
Posts 5764
Boards Moderated 1
Alias Born 09/15/2010

TOB

Re: None

Sunday, 12/23/2012 1:29:41 AM

Sunday, December 23, 2012 1:29:41 AM

Post# of 402700
This NYTimes article talks about drug trials targeting p53 in cancer cells but doesn't mention the kevetrin trials by Cellceutix.

You can register for a free account and click "recommend" on comments by biomanbaba and KarinCA. As of now, more than 67 "recommend" is the top Reader Picks comment.

At the bottom of the article click "All" and "Read More Comments"

Let's get in gear here, register, and get these comments as the top rated.

Here is the link for a free registration:

https://myaccount.nytimes.com/register

Here is the article:

http://www.nytimes.com/2012/12/23/health/new-drugs-aim-to-make-cells-destroy-cancer.html

Once you register click these direct links to the comment by:

KarinCA

biomanbaba

Darrel

and click "Recommend".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News